K200921 is an FDA 510(k) clearance for the qER. Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.
Submitted by Qure.Ai Technologies (Mumbai, IN). The FDA issued a Cleared decision on June 17, 2020 after a review of 72 days - a notably fast clearance cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Qure.Ai Technologies devices